The short version
17 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Cystex Plus
methenamine, sodium salicylate · METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 · Tablet · Oral · Clarion Brands, LLC
NDC 69693-0512-20 · 1 BLISTER PACK in 1 CARTON / 20 TABLET in 1 BLISTER PACK · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for methenamine, sodium salicylate (oral solid) in the next 90 days
sole-source market · price up 5% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedJan 24, 2022Ultra Seal Corporation — cGMP deviations
Manufacturers of methenamine, sodium salicylate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Clarion Brands, LLC | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| AmerisourceBergen Drug Corp | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amol Pharmaceuticals Private Limited | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amol Pharmaceuticals Private Limited | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cadence Health, Inc. | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Consortium, LLC | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| i-Health, Inc. | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Meijer Distribution Inc. | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Nuvicare Llc | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Aug 12, 2026 | Sep 2, 2026 |
| Pioneer Life Sciences, Llc | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Aug 12, 2026 | Sep 2, 2026 |
| Reese Pharmaceutical Co | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rite Aid | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Topco Associates LLC | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Marketing Association | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| CVS Pharmacy, Inc | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Aug 29, 2026 |
| Walgreen Company | METHENAMINE 162 mg/1; SODIUM SALICYLATE 162.5 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Cystex Plus — NDC 69693-0512-20," retrieved September 3, 2026, https://drugdashboards.com/drug/69693051220.
Free to cite with attribution — see how the data is put together.